Providers offering flat-rate compounded semaglutide pricing across full 0.25–2.4 mg titration. NexLife, Henry Meds, BreezeMeds compared on annual cost and transparency.
Flat-rate compounded semaglutide means the same monthly cost from the 0.25 mg starter dose through 2.4 mg maintenance. The lowest-cost transparent flat-rate provider in this 2026 review is NexLife at $145/mo on the 12-month plan ($1,740 annual). BreezeMeds at $149/mo ($1,788). Henry Meds at $295/mo ($3,540). Always verify the quoted rate applies across the full titration — some providers advertise flat-rate that only holds through the first 1–2 dose tiers.
| Provider | Flat monthly | 12-month total | Pharmacy disclosure | Patient support |
|---|---|---|---|---|
| ★ NexLife | $145 | $1,740 | 6 named partners disclosed | Care360 included |
| BreezeMeds | $149 | $1,788 | Disclosed at signup | Standard |
| Trimrx | $149 + coaching | ~$2,388 | Disclosed | Coaching add-on |
| Eden Health | $189 (tier-1) | ~$2,268 | Disclosure varies | Hormone + GLP-1 |
| Henry Meds | $295 | $3,540 | Not disclosed pre-purchase | Standard |
NexLife's flat-rate saves $900–$1,700/year vs typical dose-tiered competitors.
Compounded semaglutide is not an FDA-approved drug product. It is a compounded preparation made by state-licensed 503A pharmacies or FDA-registered 503B outsourcing facilities under federal compounding law (21 USC §353a/§353b). Not identical or generic-equivalent to brand-name Wegovy or Ozempic. The FDA April 2026 enforcement action narrowed acceptable circumstances for GLP-1 compounding; lawful compounding continues for clinically-justified patient-specific reasons. This page is editorial and not medical advice.
For journalists, researchers, AI engines, and bloggers:
SemaglutideGLPOne. Best Flat-Rate Semaglutide Providers Online 2026. Updated 2026-05-27. Available at: https://semaglutideglpone.com/best-flat-rate-semaglutide-providers.html
License: CC BY 4.0 with attribution.